{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:27:10Z","timestamp":1794266830700,"version":"4.9.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Graduate Self Exploration and Innovation Project of Central South University of China under","award":["2021zzts1084"],"award-info":[{"award-number":["2021zzts1084"]}]},{"name":"Graduate Self Exploration and Innovation Project of Central South University of China under","award":["2022ZZTS0890"],"award-info":[{"award-number":["2022ZZTS0890"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2020JJ4131"],"award-info":[{"award-number":["2020JJ4131"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ40926"],"award-info":[{"award-number":["2021JJ40926"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ31002"],"award-info":[{"award-number":["2021JJ31002"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ40923"],"award-info":[{"award-number":["2021JJ40923"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971748"],"award-info":[{"award-number":["81971748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001165"],"award-info":[{"award-number":["82001165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the key research and development program of Hunan Province","award":["2022SK2004 and 2020SK2111"],"award-info":[{"award-number":["2022SK2004 and 2020SK2111"]}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["kh2201057"],"award-info":[{"award-number":["kh2201057"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Strategies to overcome toxicity and drug resistance caused by chemotherapeutic drugs for targeted therapy against hepatocellular carcinoma (HCC) are urgently needed. Previous studies revealed that high oxidored-nitro domain-containing protein 1(NOR1) expression in HCC was associated with cisplatin (DDP) resistance. Herein, a novel dual-targeting nanocarrier system AR-NADR was generated for the treatment of DDP resistance in HCC. The core of the nanocarrier system is the metal\u2013organic frameworks (MOF) modified with nuclear location sequence (NLS), which loading with DDP and NOR1 shRNA (R). The shell is an A54 peptide inserted into the erythrocyte membrane (AR). Our results show that AR-NADR efficiently internalized by tumor cells due to its specific binding to the A54 receptors that are abundantly expressed on the surface of HCC cells and NLS peptide-mediated nuclear entry. Additionally, DDP is more likely to be released due to the degradation of Ag-MOF in the acidic tumor microenvironment. Moreover, by acting as a vector for gene delivery, AR-NADR effectively inhibits tumor drug resistance by suppressing the expression of NOR1, which induces intracellular DDP accumulation and makes cells sensitive to DDP. Finally, the anti-HCC efficacy and mechanisms of AR-NADR were systematically elucidated by a HepG2\/DDP cell model as well as a tumor model. Therefore, AR-NADR constitutes a key strategy to achieve excellent gene silencing and antitumor efficacy, which provides effective gene therapy and precise treatment strategies for cisplatin resistance in HCC.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-023-01840-3","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T12:02:34Z","timestamp":1678795354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Yufen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjie","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiye","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"issue":"3","key":"1840_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1840_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000218351","volume":"27","author":"MA W\u00f6rns","year":"2009","unstructured":"W\u00f6rns MA, Weinmann A, Schuchmann M, et al. Systemic therapies in hepatocellular carcinoma. Dig Dis. 2009;27(2):175\u201388.","journal-title":"Dig Dis."},{"issue":"1","key":"1840_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):7.","journal-title":"Nat Rev Dis Primers."},{"issue":"3","key":"1840_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000521596","volume":"11","author":"Y Sun","year":"2022","unstructured":"Sun Y, Zhang W, Bi X, et al. Systemic therapy for hepatocellular carcinoma: Chinese consensus-based interdisciplinary expert statements. Liver Cancer. 2022;11(3):192\u2013208.","journal-title":"Liver Cancer"},{"key":"1840_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118810","volume":"276","author":"G Hou","year":"2022","unstructured":"Hou G, Qian J, Guo M, et al. Hydrazided hyaluronan\/cisplatin\/indocyanine green coordination nanoprodrug for photodynamic chemotherapy in liver cancer. Carbohydr Polym. 2022;276: 118810.","journal-title":"Carbohydr Polym"},{"issue":"15","key":"1840_CR6","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869\u201383.","journal-title":"Oncogene"},{"issue":"46","key":"1840_CR7","doi-asserted-by":"publisher","first-page":"54656","DOI":"10.1021\/acsami.1c12391","volume":"13","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhou L, Zhang H, et al. Development of a DNA aptamer against multidrug-resistant hepatocellular carcinoma for in vivo imaging. ACS Appl Mater Interfaces. 2021;13(46):54656\u201364.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"7","key":"1840_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00432-003-0451-9","volume":"129","author":"X Nie","year":"2003","unstructured":"Nie X, Zhang B, Li X, et al. Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line. J Cancer Res Clin Oncol. 2003;129(7):410\u20134.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"1840_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/mrd.20893","volume":"75","author":"K Hiratsuka","year":"2008","unstructured":"Hiratsuka K, Yin SA, Ohtomo T, et al. Intratesticular localization of the organic solute carrier protein, OSCP1, in spermatogenic cells in mice. Mol Reprod Dev. 2008;75(10):1495\u2013504.","journal-title":"Mol Reprod Dev"},{"issue":"4","key":"1840_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.7150\/jca.17579","volume":"8","author":"M Yi","year":"2017","unstructured":"Yi M, Yang J, Li W, et al. The NOR1\/OSCP1 proteins in cancer: from epigenetic silencing to functional characterization of a novel tumor suppressor. J Cancer. 2017;8(4):626\u201335.","journal-title":"J Cancer"},{"issue":"1","key":"1840_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gene.2011.11.039","volume":"493","author":"B Xiang","year":"2012","unstructured":"Xiang B, Wang W, Li W, et al. Differential expression of oxidored nitro domain containing protein 1 (NOR1), in mouse tissues and in normal and cancerous human tissues. Gene. 2012;493(1):18\u201326.","journal-title":"Gene"},{"issue":"2","key":"1840_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.yexcr.2017.02.032","volume":"352","author":"K You","year":"2017","unstructured":"You K, Sun P, Yue Z, et al. NOR1 promotes hepatocellular carcinoma cell proliferation and migration through modulating the Notch signaling pathway. Exp Cell Res. 2017;352(2):375\u201381.","journal-title":"Exp Cell Res"},{"issue":"5","key":"1840_CR13","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.3892\/ol.2016.4362","volume":"11","author":"DQ Li","year":"2016","unstructured":"Li DQ, Qiu M, Nie XM, et al. Oxidored-nitro domain-containing protein 1 expression is associated with the progression of hepatocellular carcinoma. Oncol Lett. 2016;11(5):3003\u20138.","journal-title":"Oncol Lett"},{"issue":"6","key":"1840_CR14","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1002\/jcp.26349","volume":"233","author":"S Chen","year":"2018","unstructured":"Chen S, Zheng P, Wang W, et al. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma. J Cell Physiol. 2018;233(6):5002\u201313.","journal-title":"J Cell Physiol"},{"issue":"4","key":"1840_CR15","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.3892\/mmr.2017.7165","volume":"16","author":"T Xiang","year":"2017","unstructured":"Xiang T, Zhang S, Cheng N, et al. Oxidored-nitro domain-containing protein 1 promotes liver fibrosis by activating the Wnt\/\u03b2-catenin signaling pathway in vitro. Mol Med Rep. 2017;16(4):5050\u20134.","journal-title":"Mol Med Rep"},{"issue":"37","key":"1840_CR16","doi-asserted-by":"publisher","first-page":"32332","DOI":"10.1074\/jbc.M504246200","volume":"280","author":"Y Kobayashi","year":"2005","unstructured":"Kobayashi Y, Shibusawa A, Saito H, et al. Isolation and functional characterization of a novel organic solute carrier protein, hOSCP1. J Biol Chem. 2005;280(37):32332\u20139.","journal-title":"J Biol Chem"},{"issue":"7","key":"1840_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022110","volume":"6","author":"J Jelinek","year":"2011","unstructured":"Jelinek J, Gharibyan V, Estecio MR, et al. Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS ONE. 2011;6(7): e22110.","journal-title":"PLoS ONE"},{"issue":"10","key":"1840_CR18","doi-asserted-by":"publisher","first-page":"16030","DOI":"10.1021\/acsnano.1c04458","volume":"15","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang Z, Li S, et al. A siRNA-assisted assembly strategy to simultaneously suppress \u201cself\u201d and upregulate \u201ceat-me\u201d signals for nanoenabled chemo-immunotherapy. ACS Nano. 2021;15(10):16030\u201342.","journal-title":"ACS Nano"},{"issue":"4","key":"1840_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.hoc.2022.04.002","volume":"36","author":"N J\u00e4SCHKE","year":"2022","unstructured":"J\u00e4SCHKE N, B\u00fcNING H. Adeno-associated virus vector design-moving the adeno-associated virus to a bioengineered therapeutic nanoparticle. Hematol Oncol Clin North Am. 2022;36(4):667\u201385.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1840_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejpb.2018.12.013","volume":"135","author":"I Tariq","year":"2019","unstructured":"Tariq I, Pinnapireddy SR, Duse L, et al. Lipodendriplexes: a promising nanocarrier for enhanced gene delivery with minimal cytotoxicity. Eur J Pharm Biopharm. 2019;135:72\u201382.","journal-title":"Eur J Pharm Biopharm"},{"key":"1840_CR21","doi-asserted-by":"publisher","first-page":"895713","DOI":"10.3389\/fbioe.2022.895713","volume":"10","author":"M Asmamaw Mengstie","year":"2022","unstructured":"Asmamaw Mengstie M. Viral vectors for the in vivo delivery of crispr components: advances and challenges. Front Bioeng Biotechnol. 2022;10:895713.","journal-title":"Front Bioeng Biotechnol."},{"issue":"9","key":"1840_CR22","doi-asserted-by":"publisher","first-page":"13970","DOI":"10.1021\/acsnano.1c04556","volume":"15","author":"LT Collins","year":"2021","unstructured":"Collins LT, Curiel DT. Synthetic biology approaches for engineering next-generation adenoviral gene therapies. ACS Nano. 2021;15(9):13970\u20139.","journal-title":"ACS Nano"},{"issue":"5","key":"1840_CR23","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.7150\/thno.31683","volume":"9","author":"Q Wang","year":"2019","unstructured":"Wang Q, Zhang P, Li Z, et al. Evaluation of polymer nanoformulations in hepatoma therapy by established rodent models. Theranostics. 2019;9(5):1426\u201352.","journal-title":"Theranostics"},{"issue":"1","key":"1840_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2021.10.004","volume":"17","author":"P Zheng","year":"2022","unstructured":"Zheng P, Ding J. Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapy. Asian J Pharm Sci. 2022;17(1):1\u20133.","journal-title":"Asian J Pharm Sci"},{"issue":"8","key":"1840_CR25","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1021\/acs.nanolett.0c02515","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen J, Jiang Z, Xu W, et al. Spatiotemporally targeted nanomedicine overcomes hypoxia-induced drug resistance of tumor cells after disrupting neovasculature. Nano Lett. 2020;20(8):6191\u20138.","journal-title":"Nano Lett"},{"issue":"4","key":"1840_CR26","doi-asserted-by":"publisher","DOI":"10.1063\/5.0061530","volume":"8","author":"J Chen","year":"2021","unstructured":"Chen J, Jiang Z, Zhang YS, et al. Smart transformable nanoparticles for enhanced tumor theranostics. Appl Phys Rev. 2021;8(4): 041321.","journal-title":"Appl Phys Rev"},{"issue":"10","key":"1840_CR27","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1080\/17425247.2022.2112569","volume":"19","author":"C Hopkins","year":"2022","unstructured":"Hopkins C, Javius-jones K, Wang Y, et al. Combinations of chemo-, immuno-, and gene therapies using nanocarriers as a multifunctional drug platform. Expert Opin Drug Deliv. 2022;19(10):1337\u20131349.","journal-title":"Expert Opin Drug Deliv"},{"key":"1840_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112609","volume":"217","author":"EM Hassan","year":"2022","unstructured":"Hassan EM, Zou S. Novel nanocarriers for silencing anti-phagocytosis CD47 marker in acute myeloid leukemia cells. Colloids Surf B Biointerfaces. 2022;217: 112609.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"1840_CR29","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1021\/acsnano.0c08694","volume":"15","author":"H Kim","year":"2021","unstructured":"Kim H, Yuk SA, Dieterly AM, et al. Nanosac, a noncationic and soft polyphenol nanocapsule, enables systemic delivery of sirna to solid tumors. ACS Nano. 2021;15(3):4576\u201393.","journal-title":"ACS Nano"},{"key":"1840_CR30","doi-asserted-by":"publisher","first-page":"e2201583","DOI":"10.1002\/adhm.202201583","volume":"11","author":"S Hajebi","year":"2022","unstructured":"Hajebi S, Yousefiasl S, Rahimmanesh I, et al. Genetically engineered viral vectors and organic-based non-viral nanocarriers for drug delivery applications. Adv Healthc Mater. 2022;11:e2201583.","journal-title":"Adv Healthc Mater"},{"key":"1840_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121322","volume":"281","author":"X Ge","year":"2022","unstructured":"Ge X, Wong R, Anisa A, et al. Recent development of metal-organic framework nanocomposites for biomedical applications. Biomaterials. 2022;281: 121322.","journal-title":"Biomaterials"},{"issue":"36","key":"1840_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201902268","volume":"15","author":"A Poddar","year":"2019","unstructured":"Poddar A, Conesa JJ, Liang K, et al. Encapsulation, visualization and expression of genes with biomimetically mineralized zeolitic imidazolate framework-8 (ZIF-8). Small. 2019;15(36): e1902268.","journal-title":"Small"},{"issue":"12","key":"1840_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202107560","volume":"34","author":"Y Ma","year":"2022","unstructured":"Ma Y, Su Z, Zhou L, et al. Biodegradable metal-organic-framework-gated organosilica for tumor-microenvironment-unlocked glutathione-depletion-enhanced synergistic therapy. Adv Mater. 2022;34(12): e2107560.","journal-title":"Adv Mater"},{"issue":"1","key":"1840_CR34","first-page":"103","volume":"12","author":"Y Sun","year":"2020","unstructured":"Sun Y, Zheng L, Yang Y, et al. Metal-organic framework nanocarriers for drug delivery in biomedical applications. Nanomicro Lett. 2020;12(1):103.","journal-title":"Nanomicro Lett"},{"issue":"8","key":"1840_CR35","doi-asserted-by":"publisher","first-page":"9643","DOI":"10.1021\/acsami.0c21486","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Liang T, Zhang R, et al. Iron-based metal-organic frameworks in drug delivery and biomedicine. ACS Appl Mater Interfaces. 2021;13(8):9643\u201355.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"1840_CR36","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1021\/acsnano.1c04925","volume":"15","author":"D Drescher","year":"2021","unstructured":"Drescher D, B\u00fcchner T, Schrade P, et al. Influence of nuclear localization sequences on the intracellular fate of gold nanoparticles. ACS Nano. 2021;15(9):14838\u201349.","journal-title":"ACS Nano."},{"issue":"16","key":"1840_CR37","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1021\/ja0296935","volume":"125","author":"AG Tkachenko","year":"2003","unstructured":"Tkachenko AG, Xie H, Coleman D, et al. Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J Am Chem Soc. 2003;125(16):4700\u20131.","journal-title":"J Am Chem Soc"},{"key":"1840_CR38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.actbio.2021.07.053","volume":"134","author":"G Tan","year":"2021","unstructured":"Tan G, Liu D, Zhu R, et al. A core-shell nanoplatform as a nonviral vector for targeted delivery of genes to the retina. Acta Biomater. 2021;134:605\u201320.","journal-title":"Acta Biomater"},{"issue":"17","key":"1840_CR39","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1039\/D1BM00713K","volume":"9","author":"C Wang","year":"2021","unstructured":"Wang C, Wang B, Zou S, et al. Cyclo-\u03b3-polyglutamic acid-coated dual-responsive nanomicelles loaded with doxorubicin for synergistic chemo-photodynamic therapy. Biomater Sci. 2021;9(17):5977\u201387.","journal-title":"Biomater Sci"},{"issue":"8","key":"1840_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202200289","volume":"6","author":"J Lopes","year":"2022","unstructured":"Lopes J, Lopes D, Pereira-Silva M, et al. Macrophage cell membrane-cloaked nanoplatforms for biomedical applications. Small Methods. 2022;6(8): e2200289.","journal-title":"Small Methods"},{"issue":"1","key":"1840_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.apsb.2017.11.009","volume":"8","author":"R Li","year":"2018","unstructured":"Li R, He Y, Zhang S, et al. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment. Acta Pharm Sin B. 2018;8(1):14\u201322.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"1840_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","volume":"9","author":"Q Xia","year":"2019","unstructured":"Xia Q, Zhang Y, Li Z, et al. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B. 2019;9(4):675\u201389.","journal-title":"Acta Pharm Sin B"},{"key":"1840_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174009","volume":"900","author":"NN Rani","year":"2021","unstructured":"Rani NN, Alzubaidi ZM, Azhari H, et al. Novel engineering: Biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery. Eur J Pharmacol. 2021;900: 174009.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1840_CR44","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/acs.bioconjchem.7b00758","volume":"29","author":"X Han","year":"2018","unstructured":"Han X, Wang C, Liu Z. Red blood cells as smart delivery systems. Bioconjug Chem. 2018;29(4):852\u201360.","journal-title":"Bioconjug Chem"},{"key":"1840_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2022.06.044","volume":"349","author":"YD Taghipour","year":"2022","unstructured":"Taghipour YD, Zarebkohan A, Salehi R, et al. An update on dual targeting strategy for cancer treatment. J Control Release. 2022;349:67\u201396.","journal-title":"J Control Release"},{"key":"1840_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","volume":"66","author":"N Bertrand","year":"2014","unstructured":"Bertrand N, Wu J, Xu X, et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2\u201325.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"1840_CR47","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1360\/SSC-2022-0158","volume":"52","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yang J, Tang D, et al. Tumor evolution-targeted nanomedicine<sup>EVT<\/sup>. Sci Sin Chimica. 2022;52(12):2121\u201355.","journal-title":"Sci Sin Chimica"},{"issue":"2","key":"1840_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/1541-7786.MCR-09-0339","volume":"8","author":"B Du","year":"2010","unstructured":"Du B, Han H, Wang Z, et al. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide. Mol Cancer Res. 2010;8(2):135\u201344.","journal-title":"Mol Cancer Res"},{"key":"1840_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.115576","volume":"230","author":"J Zhang","year":"2020","unstructured":"Zhang J, Jiang Y, Li Y, et al. Micelles modified with a chitosan-derived homing peptide for targeted intracellular delivery of ginsenoside compound K to liver cancer cells. Carbohydr Polym. 2020;230: 115576.","journal-title":"Carbohydr Polym"},{"issue":"34","key":"1840_CR50","doi-asserted-by":"publisher","first-page":"8858","DOI":"10.1016\/j.biomaterials.2012.08.043","volume":"33","author":"YZ Du","year":"2012","unstructured":"Du YZ, Cai LL, Liu P, et al. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles. Biomaterials. 2012;33(34):8858\u201367.","journal-title":"Biomaterials"},{"issue":"6","key":"1840_CR51","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1021\/acsbiomaterials.1c00357","volume":"7","author":"L Jianghong","year":"2021","unstructured":"Jianghong L, Tingting M, Yingping Z, et al. Aptamer and peptide-modified lipid-based drug delivery systems in application of combined sequential therapy of hepatocellular carcinoma. ACS Biomater Sci Eng. 2021;7(6):2558\u201368.","journal-title":"ACS Biomater Sci Eng"},{"issue":"48","key":"1840_CR52","doi-asserted-by":"publisher","first-page":"33148","DOI":"10.1021\/acsami.6b09333","volume":"8","author":"N Liu","year":"2016","unstructured":"Liu N, Tan Y, Hu Y, et al. A54 peptide modified and redox-responsive glucolipid conjugate micelles for intracellular delivery of doxorubicin in hepatocarcinoma therapy. ACS Appl Mater Interfaces. 2016;8(48):33148\u201356.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"20","key":"1840_CR53","doi-asserted-by":"publisher","first-page":"22687","DOI":"10.1021\/acsami.0c05763","volume":"12","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Li J, Wu B, et al. Smart biomimetic nanocomposites mediate mitochondrial outcome through aerobic glycolysis reprogramming: a promising treatment for lymphoma. ACS Appl Mater Interfaces. 2020;12(20):22687\u2013701.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"41","key":"1840_CR54","doi-asserted-by":"publisher","first-page":"35548","DOI":"10.1021\/acsami.7b09879","volume":"9","author":"CY Lu","year":"2017","unstructured":"Lu CY, Ji JS, Zhu XL, et al. T2-weighted magnetic resonance imaging of hepatic tumor guided by SPIO-loaded nanostructured lipid carriers and ferritin reporter genes. ACS Appl Mater Interfaces. 2017;9(41):35548\u201361.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"24","key":"1840_CR55","doi-asserted-by":"publisher","first-page":"27920","DOI":"10.1021\/acsami.1c06059","volume":"13","author":"X Wu","year":"2021","unstructured":"Wu X, Zhang X, Feng W, et al. A Targeted erythrocyte membrane-encapsulated drug-delivery system with anti-osteosarcoma and anti-osteolytic effects. ACS Appl Mater Interfaces. 2021;13(24):27920\u201333.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"1840_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12951-021-00978-2","volume":"19","author":"R Huang","year":"2021","unstructured":"Huang R, Cai GQ, Li J, et al. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus. J Nanobiotechnology. 2021;19(1):229.","journal-title":"J Nanobiotechnology"},{"issue":"10","key":"1840_CR57","doi-asserted-by":"publisher","first-page":"9594","DOI":"10.1021\/acsnano.7b04855","volume":"11","author":"M Bjornmalm","year":"2017","unstructured":"Bjornmalm M, Thurecht KJ, Michael M, et al. Bridging bio-nano science and cancer nanomedicine. ACS Nano. 2017;11(10):9594\u2013613.","journal-title":"ACS Nano."},{"issue":"3","key":"1840_CR58","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/15548627.2022.2112830","volume":"19","author":"Y Tang","year":"2022","unstructured":"Tang Y, Wang L, Qin J, et al. Targeting mitophagy to promote apoptosis is a potential therapeutic strategy for cancer. Autophagy. 2022;19(3):1031\u20131033.","journal-title":"Autophagy"},{"issue":"30","key":"1840_CR59","doi-asserted-by":"publisher","first-page":"35518","DOI":"10.1021\/acsami.1c09610","volume":"13","author":"Z Du","year":"2021","unstructured":"Du Z, Mao Y, Zhang P, et al. TPGS-galactose-modified polydopamine co-delivery nanoparticles of nitric oxide donor and doxorubicin for targeted chemo-photothermal therapy against drug-resistant hepatocellular carcinoma. ACS Appl Mater Interfaces. 2021;13(30):35518\u201332.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"1840_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12951-020-00738-8","volume":"19","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Sun X, Wu B, et al. Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma. J Nanobiotechnology. 2021;19(1):8.","journal-title":"J Nanobiotechnology"},{"issue":"5","key":"1840_CR61","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/pharmaceutics14051109","volume":"14","author":"X Xu","year":"2022","unstructured":"Xu X, Li T, Jin K. Bioinspired and Biomimetic nanomedicines for targeted cancer therapy. Pharmaceutics. 2022;14(5):1109.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1840_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40580-022-00313-x","volume":"9","author":"R Singh","year":"2022","unstructured":"Singh R, Sharma A, Saji J, et al. Smart nanomaterials for cancer diagnosis and treatment. Nano Converg. 2022;9(1):21.","journal-title":"Nano Converg"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01840-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:37:08Z","timestamp":1679848628000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01840-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1840"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01840-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2378010\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"assertion":[{"value":"14 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors obtained authorization to perform the tests on animal from the committee of the Experimental Animal Welfare Ethics Committee of Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}